Literature DB >> 15162048

Transgenerational transmission of radiation- and chemically induced tumors and congenital anomalies in mice: studies of their possible relationship to induced chromosomal and molecular changes.

T Nomura1, H Nakajima, H Ryo, L Y Li, Y Fukudome, S Adachi, H Gotoh, H Tanaka.   

Abstract

This article provides a broad overview of our earlier studies on the induction of tumors and congenital anomalies in the progeny of X-irradiated or chemically treated mice and our subsequent (published, hitherto unpublished and on-going) investigations aimed at identifying potential relationships between genetic changes induced in germ cells and the adverse effects manifest as tumors and congenital anomalies using cytogenetic and molecular approaches. The earlier studies document the fact that tumors and congenital anomalies can be induced by irradiation or treatment with certain chemicals such as urethane and that these phenotypes are heritable i.e., transmitted to generations beyond the first generation. These findings support the view that transmissible induced genetic changes are involved. The induced rates of congenital abnormalities and tumors are about two orders of magnitude higher than those recorded in the literature from classical mutation studies with specific locus mutations. The cytogenetic studies addressed the question of whether there were any relationships between induced translocations and induced tumors. The available data permit the inference that gross chromosomal changes may not be involved but do not exclude smaller induced genetic changes that are beyond the resolution of the techniques used in these studies. Other work on possible relationship between visible chromosomal anomalies (in bone marrow preparations) and tumors were likewise negative. However, there were indications that some induced cytogenetic changes might underlie induced congenital anomalies, i.e., trisomies, deletions and inversions were observed in induced and transmissible congenital anomalies (such as dwarfs, tail anomalies). Studies that explored possible relationships between induction of minisatellite mutations at the Pc-3 locus and tumors were negative. However, gene expression analysis of tumor (hepatoma)-susceptible offspring of progeny descended from irradiated male mice showed abnormal expression of many genes. Of these, only very few were oncogenes. This lends some support to our hypothesis that cumulative changes in gene expression of many genes, which perform normal cellular functions, may contribute to the occurrence of tumors in the offspring of irradiated or chemically treated mice. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162048     DOI: 10.1159/000077499

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  4 in total

1.  Transgenerational accumulation of radiation damage in small mammals chronically exposed to Chernobyl fallout.

Authors:  Nadezhda I Ryabokon; R I Goncharova
Journal:  Radiat Environ Biophys       Date:  2006-07-22       Impact factor: 1.925

Review 2.  Seminiferous cord formation and germ-cell programming: epigenetic transgenerational actions of endocrine disruptors.

Authors:  Michael K Skinner; Matthew D Anway
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

Review 3.  Dioxin induction of transgenerational inheritance of disease in zebrafish.

Authors:  Tracie R Baker; Tisha C King-Heiden; Richard E Peterson; Warren Heideman
Journal:  Mol Cell Endocrinol       Date:  2014-09-03       Impact factor: 4.102

4.  Reduced mRNA and protein expression of the genomic caretaker RAD9A in primary fibroblasts of individuals with childhood and independent second cancer.

Authors:  Eva Weis; Holger Schoen; Anja Victor; Claudia Spix; Marco Ludwig; Brigitte Schneider-Raetzke; Nicolai Kohlschmidt; Oliver Bartsch; Aslihan Gerhold-Ay; Nils Boehm; Franz Grus; Thomas Haaf; Danuta Galetzka
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.